| Literature DB >> 32171920 |
Fataneh Tavasolian1, Abbas Shapouri Moghaddam2, Fattah Rohani3, Elham Abdollahi4, Ehsan Janzamin5, Amir Abbas Momtazi-Borojeni6, Seyed Adel Moallem7, Tannaz Jamialahmadi8, Amirhossein Sahebkar9.
Abstract
Rheumatoid arthritis is a well-known chronic inflammatory joint disorder. It encompasses systemic inflammation, autoimmunity and development of several joint abnormalities leading to the lifelong disability and increased mortality. Exosomes are nano-sized (30-100 nm) mammalian extracellular particles with essential properties to regulate biological processes and cellular signaling by transferring protein and genetic materials. Understanding the diversity in the exosomal contents and their corresponding targets may contribute to better recognition of the processes that are implicated in the development and progression of diseases such as autoimmune disorders. Exosomes may act as a potential biomarker for the diagnosis of autoimmune disorders. In the present review, we aimed to bring together the relevant evidence on the biology of exosomes in rheumatoid arthritis, and also discuss the recent findings regarding the diagnostic, prognostic and therapeutic promise of these nanoparticles.Entities:
Keywords: Cell signaling; Exosome, rheumatoid arthritis; Inflammation
Year: 2020 PMID: 32171920 DOI: 10.1016/j.autrev.2020.102511
Source DB: PubMed Journal: Autoimmun Rev ISSN: 1568-9972 Impact factor: 9.754